ZAc 15733.0
(0.22%)
Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|---|
Operating Cash Flow | 15.65 Billion | 9.94 Billion | 6.92 Billion | 9.17 Billion | 272.07 Million | 4.68 Billion |
Net Income | 8.58 Billion | 6.6 Billion | -1.05 Billion | 6.38 Billion | -595 Million | -2.74 Billion |
Depreciation & Amortization | 4.64 Billion | 3.45 Billion | 3.68 Billion | 3.87 Billion | 3.5 Billion | 4.05 Billion |
Deferred income taxes | - | -10.49 Billion | -3.06 Billion | -11.57 Billion | -2.39 Billion | -1.9 Billion |
Stock-based compensation | - | 112 Million | 145 Million | 160 Million | 180 Million | 230 Million |
Change in working capital | - | -317 Million | -159 Million | 591 Million | -548 Million | -2 Million |
Other non-cash items | 2.41 Billion | 10.58 Billion | 7.37 Billion | 9.74 Billion | 120.57 Million | 5.05 Billion |
Investing Cash Flow | -8.36 Billion | -10.59 Billion | -6.2 Billion | -8.46 Billion | -204.96 Million | -4.8 Billion |
Investments in PPE | -8.39 Billion | -7.64 Billion | -6.21 Billion | -5.14 Billion | -207.96 Million | -5.03 Billion |
Acquisitions | 4 Million | -2.99 Billion | 24 Million | -3.32 Billion | 59 Million | 28.37 Million |
Investment purchases | -21 Million | -138 Million | -128 Million | -48 Million | -21 Million | -15 Million |
Sales/Maturities of investments | 120 Million | 58 Million | 53 Million | 70 Million | 64 Million | 219 Million |
Other Investing Activities | -66 Million | 120 Million | 65 Million | -17 Million | -99 Million | -5.37 Million |
Financing Cash Flow | -5.43 Billion | 1.19 Billion | -1.15 Billion | -4.29 Billion | 247.99 Million | 383.07 Million |
Debt repayment | -3.74 Billion | -2.27 Billion | -3.77 Billion | -3.61 Billion | -328.3 Million | -1.34 Billion |
Dividends payments | -1.43 Billion | -154 Million | -430 Million | -684 Million | -3 Million | - |
Common Stock Repurchased | - | - | - | - | -2.88 Billion | - |
Common Stock Issuance | - | - | - | - | 3.46 Billion | 212.81 Million |
Other Financing Activities | -251 Million | 3.61 Billion | 3.05 Billion | -5 Million | -3 Million | 1.51 Billion |
Accounts receivables | - | -33.31 Million | 1.29 Million | -23.72 Million | -20.1 Million | 32 Million |
Accounts payables | - | 618 Million | 52 Million | 967 Million | -49 Million | 54 Million |
Inventory | - | -308 Million | -232 Million | -37 Million | -150 Million | -88 Million |
Other working capital | - | -593.68 Million | 19.7 Million | -315.27 Million | -328.89 Million | - |
Cash at beginning of period | 2.9 Billion | 2.44 Billion | 2.81 Billion | 6.35 Billion | 70.49 Million | 723.57 Million |
Cash at end of period | 4.73 Billion | 2.86 Billion | 2.44 Billion | 2.81 Billion | 366.2 Million | 993.14 Million |
Capital Expenditure | -8.39 Billion | -7.64 Billion | -6.21 Billion | -5.14 Billion | -207.96 Million | -5.03 Billion |
Effect of forex changes on cash | - | -127 Million | 56 Million | 46 Million | -6.1 Million | 14.18 Million |
Net cash flow / Change in cash | 1.82 Billion | 419 Million | -371 Million | -3.53 Billion | 295.71 Million | 269.56 Million |
Free Cash Flow | 7.25 Billion | 2.3 Billion | 710 Million | 4.03 Billion | 64.11 Million | -354.69 Million |
Breakdown | 2023 Q4 | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 | 2022 Q3 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 2.66 Billion | 5.92 Billion | 156.33 Million | 6.6 Billion | 2.98 Billion | 83.71 Million |
Depreciation & Amortization | 2.21 Billion | 2.43 Billion | 62.87 Million | 3.45 Billion | 1.66 Billion | 47.88 Million |
Deferred income taxes | - | - | - | -10.49 Billion | -3.3 Billion | 23.11 Million |
Stock-based compensation | - | 738.06 Thousand | 713 Thousand | 112 Million | 2.25 Million | 2.38 Million |
Change in working capital | - | - | - | -317 Million | -24.83 Million | -26.25 Million |
Other non-cash items | 3.77 Billion | 3.5 Billion | -35.2 Million | 10.58 Billion | 5.56 Billion | 85.57 Million |
Investing Cash Flow | -4.63 Billion | -3.72 Billion | -98.44 Million | -10.59 Billion | -3.91 Billion | -110 Million |
Investments in PPE | -4.53 Billion | -3.86 Billion | -102.14 Million | -7.64 Billion | -3.99 Billion | -112.16 Million |
Acquisitions | 2 Million | 2 Million | - | -2.99 Billion | 7 Million | 84.13 Million |
Investment purchases | -9 Million | -12 Million | - | -138 Million | -16 Million | - |
Sales/Maturities of investments | - | 120 Million | - | 58 Million | 58 Million | - |
Other Investing Activities | -96 Million | 30 Million | 3.69 Million | 120 Million | 28 Million | -81.97 Million |
Financing Cash Flow | -2.69 Billion | -2.74 Billion | -72.46 Million | 1.19 Billion | -2.13 Billion | -59.84 Million |
Debt repayment | -1.62 Billion | -2.12 Billion | - | -2.27 Billion | -2.04 Billion | - |
Dividends payments | -1.43 Billion | -12.71 Million | -12.27 Million | -154 Million | -154 Million | -28.08 Thousand |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | 366 Million | -486 Million | -60.18 Million | 3.61 Billion | 145 Million | -59.81 Million |
Accounts receivables | - | - | - | -33.31 Million | -16.65 Million | -17.6 Million |
Accounts payables | - | - | - | 618 Million | - | - |
Inventory | - | - | - | -308 Million | -8.18 Million | -8.64 Million |
Other working capital | - | - | - | -593.68 Million | - | - |
Cash at beginning of period | 3.47 Billion | 2.9 Billion | - | 2.44 Billion | 2.22 Billion | 129.17 Million |
Cash at end of period | 4.73 Billion | 3.47 Billion | 15.02 Million | 2.86 Billion | 2.9 Billion | 18.87 Million |
Capital Expenditure | -4.53 Billion | -3.86 Billion | -102.14 Million | -7.64 Billion | -3.99 Billion | -112.16 Million |
Effect of forex changes on cash | - | 1.25 Million | 1.21 Million | -127 Million | -4.33 Million | -4.57 Million |
Net cash flow / Change in cash | 1.25 Billion | 569 Million | 15.02 Million | 419 Million | 679 Million | -110.29 Million |
Free Cash Flow | 4.12 Billion | 3.12 Billion | 82.57 Million | 2.3 Billion | 2.88 Billion | 81.13 Million |
PAT
GROC
6622
AAREYDRUGS
SUGALDAM
SHIVAGR